Rajshree Polypack Limited has informed the Exchange regarding Allotment of 9,00,000 equity shares on conversion of Fully Convertible Warrants & consequential changes in the paid-up equity share capital. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our earlier intimation dated December 11, 2023 regarding allotment of total Fully Convertible Warrants ( Warrants ) by way of preferential allotment on private placement basis to the persons belonging to Non-Promoter, Public Category , we would like to further inform that the Board of Directors of the Company vide a resolution passed by Circulation on June 07, 2025 has allotted 9,00,000 equity shares of face value of ₹ 5/- (Rupee One Only) each, on conversion of 1,50,000 Warrants, to 4 Allottees belonging to Non-Promoter, Public Category .
RPPL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rajshree Polypack Limited has allotted 9,00,000 equity shares (face value ₹5 each) to 4 non-promoter allottees upon conversion of 1,50,000 Fully Convertible Warrants. The company received ₹2.35 crore as the balance 75% amount at ₹156.75 per warrant (original warrant issue price ₹209). The conversion price works out to ₹104.50 per equity share including a premium of ₹99.50. As a result, paid-up share capital rose from ₹36.67 crore to ₹37.12 crore, with total equity shares increasing from 7.33 crore to 7.42 crore. The original warrants were issued in December 2023 on a preferential basis, and share counts have been adjusted for a prior 2:1 bonus issue and a stock split from ₹10 to ₹5 face value. Another 1,50,000 warrants remain pending conversion by certain allottees within the 18-month window.
The conversion results in a minor equity dilution of about 1.2% (9 lakh shares added to 7.33 crore base) and brings in ₹2.35 crore to the company. The new shares rank pari-passu with existing shares for dividend and voting, so existing shareholders will see a small dilution in their stake. No major price action is expected from this routine regulatory disclosure, though further warrant conversions remain pending.